Max Healthcare Institute Limited — Investor Meet, 06-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

**Financial Performance:** Max Healthcare reported a robust performance with a 34% year-on-year growth in network gross revenue, totaling ₹2,381 crore. EBITDA reached ₹622 crore, reflecting a 32% increase year-on-year. Net profit before exceptional items rose 15% to ₹390 crore. The network operating EBITDA margin stood at 27.3%, showcasing operational efficiency despite a challenging quarter typically marked by lower activity due to festive seasons.

**Future Outlook and Growth Drivers:** Management expressed confidence in continued growth from strategic acquisitions and new hospital launches. They are expanding in the Mumbai Metropolitan Region with a new 500-bed facility in Thane, aiming for operational readiness by 2028. Further enhancements in capacity at existing facilities, particularly in Mohali, signal a proactive approach to meet future demand.

**Order Book and Operational Updates:** In Q3, significant contributions came from acquired hospitals, including Jaypee Noida, which generated ₹112 crore in revenue. Ongoing capacity expansion projects are on track, with completion timelines maintained for facilities like Max Lucknow and Max Nagpur.

**Analyst Q&A Insights:** Analysts inquired about revenue stability and growth potential amidst seasonal variations. Management attributed flat quarter-on-quarter revenue primarily to favorable occupancy during traditionally weaker periods. Concerns regarding the competitive landscape were addressed, with management indicating their intent to maintain profitability through operational efficiencies and strategic expansions.

**Market or Regulatory Updates:** Discussions also touched on insurance pricing dynamics and potential impact from regulatory changes, with management portraying limited risk to revenue from such developments.

**Strategic Focus Areas:** Max Healthcare is focused on leveraging operational synergies from acquired and new facilities to drive profitability. The strategic emphasis is on enhancing outpatient services and specialized care opportunities, particularly in oncology.

**Investor Insight:** The company's healthy financial metrics, growing revenue streams from existing and new facilities, and strategic acquisitions suggest a favorable outlook. Aligning with their growth and operational strategy, a ‘buy’ position could be considered, especially given the promising expansion plans and manageable debt levels.